SA
PRCT icon

SpiderRock Advisors’s Procept Biorobotics PRCT Stock Holding History

SpiderRock Advisors’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$787K Hold
9,817
– – 0.01% 517
2024
Q2 		$600K Buy
9,817
+3,508
+56% +$209K 0.01% 515
2024
Q1 		$307K Buy
+6,309
New +$300K 0.01% 623

Other funds holding PRCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

SpiderRock Advisors's PRCT Position: Q3 2024 in Review

SpiderRock Advisors held its Procept Biorobotics (PRCT) position steady in Q3 2024 at 9,817 shares worth $787K. The position accounts for 0.01% of the portfolio, ranked #517.

SpiderRock Advisors first reported a position in PRCT in Q1 2024 and has held it in 3 quarters since. 250 funds tracked by Wall St. Rank hold PRCT as of Q3 2024.

  • SpiderRock Advisors held 9,817 shares of Procept Biorobotics worth $787K as of Q3 2024.
  • SpiderRock Advisors left its Procept Biorobotics share count unchanged in Q3 2024.
  • Procept Biorobotics made up 0.01% of SpiderRock Advisors's portfolio in Q3 2024, its #517 holding.
  • SpiderRock Advisors first reported a position in Procept Biorobotics in Q1 2024 and has held it in 3 quarters since.
  • 250 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2024.

Based on SpiderRock Advisors's 13F filing for Q3 2024, filed 1 Nov 2024.